Skip to main content

Table 5 Impairment in work productivity in employed patients (WPAI:IBS-C questionnaire) and daily activities in all patients with moderate to severe IBS-C at baseline and 6 months

From: Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries

  

FRANCE

GERMANY

ITALY

SPAIN

SWEDEN

UK

 

Total

59

102

112

112

36

104

Presenteeism, % a

N

27

52

66

45

24

58

Baseline

44.4 (32.9)

35.6 (28.2)

27.6 (27.7)

29.2 (27.5)

41.3 (22.1)

47.9 (28.7)

N

15

49

65

49

20

41

6 Months

43.3 (27.7)

32.2 (24.9)

25.4 (21.4)

27.1 (23.9)

34.0 (21.4)

38.0 (28.0)

Absenteeism, %a

N

21

43

63

46

22

51

Baseline

18.5 (34.9)

14.7 (28.2)

3.1 (9.3)

6.1 (15.8)

6.9 (12.4)

8.4 (24.2)

N

9

33

60

49

18

38

6 Months

0.9 (2.8)

3.2 (9.1)

0.9 (3.7)

2.9 (5.0)

2.7 (6.7)

7.0 (22.6)

Overall work productivity loss, %a

N

21

43

62

50

22

49

Baseline

46.3 (33.2)

44.1 (32.7)

27.7 (28.6)

32.3 (27.2)

44.4 (24.9)

51.5 (27.2)

N

9

33

60

55

18

37

6 Months

39.6 (29.3)

32.0 (25.7)

26.1 (22.0)

29.8 (24.0)

32.4 (20.2)

39.1 (27.2)

Daily activity impairment, %

N

52

95

110

104

35

99

Baseline

48.1 (29.0)

36.3 (24.8)

41.1 (29.1)

39.6 (27.2)

48.0 (25.4)

56.8 (29.6)

N

37

92

105

97

30

72

6 Months

50.5 (28.2)

38.0 (23.3)

33.0 (25.1)

37.9 (26.3)

43.0 (28.4)

51.4 (31.7)

  1. aEmployed patients. All values are presented as mean (SD)